Posted in Fibroid Relief News

Executive Director of Fibroid Relief, Justine Atkinson, Speaks at FDA Advisory Committee Meeting Regarding the Future of Morcellator Devices

Posted in Fibroid Relief News

Executive Director of Fibroid Relief, Justine Atkinson, stood among clinical experts and government decision makers in Silver Spring, MD, on July 10, 2014, at an FDA Advisory Committee Meeting regarding the future of morcellator devices used during some procedures to treat fibroids. The FDA recently cautioned the use of morcellators, citing their potential to spread cancer. Justine addressed other, less-invasive procedures that do not use morcellators and highlighted the importance of women having access to and understanding the risks and benefits of the treatment they choose.

Read her statement.

Share
Comments are closed, but we welcome discussion! Please visit our Facebook Page to discuss this or other news stories, as well as connect with others interested in Uterine Fibroids.
Tags: , , , , , , ,